Overview
- Researchers and an amfAR partner survey released July 21, 2026 report that terminations and payment delays tied to U.S. policy changes closed more than 1,700 clinics and cost over 16,000 full-time jobs.
- PEPFAR prevention spending fell about 51% from fiscal year 2024 to 2025, leading many groups to stop condom distribution and PrEP services and 43% to end at least one prevention activity.
- Independent studies presented through mid-2026 found large treatment losses, including nearly 2 million fewer people on PEPFAR-supported antiretroviral therapy in FY2025 and about 77,000 fewer children receiving U.S.-supported pediatric treatment to October 2025.
- Locally based and key-population organizations were hit hardest, with many forced to stop services for sex workers, men who have sex with men, transgender people, and people who inject drugs, fracturing community testing and outreach networks.
- Authors and advocates call for immediate re‑investment in prevention and community-led groups, targeted contracts with local NGOs, and time to rebuild trust and systems to avoid reversing decades of progress.